OnKure Therapeutics OKUR
NASDAQ OKUR
$2.58 +0.28 (+12.17%)
At close: Oct 22, 2026 · 4:00 PM EDT

OnKure Therapeutics (OKUR) Preferred Stock Liabilities (2020 - 2023)

Updated

OnKure Therapeutics' Preferred Stock Liabilities was $129.83 million in Q4 2023.

Analysis

OnKure Therapeutics (OKUR) Preferred Stock Liabilities (2020 - 2023) Analysis & Trends

From Q1 2020 onward, OnKure Therapeutics has reported Preferred Stock Liabilities for 6 quarters.

  • Preferred Stock Liabilities shows a three-year compound annual growth rate of 11.9% (FY2020 to FY2023).
  • In earlier years, Preferred Stock Liabilities was $92.72 million in FY2020.
  • The Q4 2023 figure marks the highest quarterly Preferred Stock Liabilities since Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 OnKure Therapeutics 104.48 Mn -393.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 129.83 Mn
Mar 31, 2021 140.08 Mn
Dec 31, 2020 92.72 Mn
Sep 30, 2020 45.65 Mn
Jun 30, 2020 45.65 Mn
Mar 31, 2020 45.65 Mn
API Access

OnKure Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=OKUR&period=max&api_key=YOUR_API_KEY